Table 2.
Population | Patients, n | Deaths, n | 15-yr survival (%) | 95% CI for 15-yr survival | HR | 95% CI for HR | P value |
---|---|---|---|---|---|---|---|
All ages | |||||||
Males | 953 | 30 | 91 | 0.86–0.94 | 1.00 | ||
Females | 2619 | 34 | 96 | 0.93–0.98 | 0.73 | 0.44–1.20 | 0.215 |
Initial age cutoff of <45 yr | |||||||
Age group <45 yr | |||||||
Males | 437 | 2 | 99 | 0.96–1.00 | 1.00 | ||
Females | 1507 | 2 | 100 | 0.98–1.00 | 0.39 | 0.05–2.88 | 0.356 |
Age group 45–59 yr | |||||||
Males | 320 | 13 | 87 | 0.75–0.93 | 1.00 | ||
Females | 731 | 11 | 91 | 0.81–0.96 | 0.55 | 0.24–1.26 | 0.159 |
Age group 60–74 yr | |||||||
Males | 156 | 10 | 81 | 0.64–0.90 | 1.00 | ||
Females | 293 | 12 | 93 | 0.88–0.96 | 0.73 | 0.31–1.70 | 0.466 |
Age group ≥75 yra | |||||||
Males | 40 | 5 | 65 | 0.27–0.86 | 1.00 | ||
Females | 88 | 9 | 85 | 0.72–0.92 | 1.19 | 0.38–3.66 | 0.767 |
Initial age cutoff of <55 yr | |||||||
Age group <55 yr | |||||||
Males | 663 | 13 | 94 | 0.89–0.97 | 1.00 | ||
Females | 2055 | 8 | 98 | 0.94–0.99 | 0.33 | 0.13–0.81 | 0.016 |
Age group 55–69 yr | |||||||
Males | 214 | 9 | 87 | 0.75–0.94 | 1.00 | ||
Females | 416 | 13 | 91 | 0.78–0.96 | 1.01 | 0.42–2.37 | 0.983 |
Age group >70 yra | |||||||
Males | 76 | 8 | 67 | 0.38–0.85 | 1.00 | ||
Females | 148 | 13 | 85 | 0.75–0.91 | 1.17 | 0.48–2.85 | 0.737 |
Initial age cutoff of less than 45 yr shows the usual staging age cutoff of less than 45 yr; the initial age cutoff of less than 55 yr shows a cutoff of less than 55 yr based on menopause. Patients younger than either 45 or 55 yr were combined as a group because there were very few deaths in these age groups. HR = 1.0 for stage I and II.
Survival probability and 95% CI were based on 10 yr, rather than 15 yr.